STAAR Surgical Company

NasdaqGM:STAA 株式レポート

時価総額:US$2.0b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

STAAR Surgical マネジメント

マネジメント 基準チェック /14

STAAR Surgical'sの CEO はTom Frinziで、 Jan2023年に任命され、 の在任期間は 1.42年です。 の年間総報酬は$ 10.22Mで、 7.7%給与と92.3%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.046%を直接所有しており、その価値は$ 912.13K 。経営陣と取締役会の平均在任期間はそれぞれ1.4年と3.4年です。

主要情報

Tom Frinzi

最高経営責任者

US$10.2m

報酬総額

CEO給与比率7.7%
CEO在任期間1.4yrs
CEOの所有権0.05%
経営陣の平均在職期間1.4yrs
取締役会の平均在任期間3.4yrs

経営陣の近況

Recent updates

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

May 27
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

Apr 26
Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher

STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge

Apr 05

STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

Mar 25
STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue

STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade

Mar 13

STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Mar 07
STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump

Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

Jan 31
Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?

With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Jan 05
With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For

Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Nov 30
Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)

Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Nov 12
Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?

Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Oct 25
Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?

Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Aug 24
Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes

Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Jul 02
Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?

Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Jun 17
Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

May 13
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Mar 26
A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Mar 12
STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital

Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Feb 13
Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?

Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Jan 28
Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today

Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

Dec 15
Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

Dec 01
The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Oct 26
What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?

Keep Adding To STAAR Surgical Longs, Buy Thesis Remains

Sep 20

Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

Sep 05
Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?

STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

Aug 21
STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate

STAAR Surgical rises 15% on Q2 result beat

Aug 11

Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now?

Jul 20
Should You Think About Buying STAAR Surgical Company (NASDAQ:STAA) Now?

STAAR Surgical: Hard Data Approach Justifies Long-Only Portfolio Allocation

Jul 05

The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

Jun 20
The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising

CEO報酬分析

STAAR Surgical の収益と比較して、Tom Frinzi の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 29 2024n/an/a

US$15m

Dec 29 2023US$10mUS$788k

US$21m

Sep 29 2023n/an/a

US$19m

Jun 30 2023n/an/a

US$25m

Mar 31 2023n/an/a

US$33m

Dec 30 2022US$274kn/a

US$40m

Sep 30 2022n/an/a

US$38m

Jul 01 2022n/an/a

US$34m

Apr 01 2022n/an/a

US$29m

Dec 31 2021US$250kn/a

US$28m

Oct 01 2021n/an/a

US$23m

Jul 02 2021n/an/a

US$21m

Apr 02 2021n/an/a

US$11m

Jan 01 2021US$182kn/a

US$6m

報酬と市場: Tomの 総報酬 ($USD 10.22M ) は、 US市場 ($USD 5.67M ) の同規模の企業の平均を上回っています。

報酬と収益: Tomの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。


CEO(最高経営責任者

Tom Frinzi (68 yo)

1.4yrs

在職期間

US$10,220,581

報酬

Mr. Thomas G. Frinzi, also known as Tom, serves as Executive Chairman of the Board at ViaLase, Inc. since November 2022 and joined the company in November 2022. He serves as Executive Chair at Aurion Biote...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Thomas Frinzi
President1.4yrsUS$10.22m0.046%
$ 938.3k
Patrick Williams
Chief Financial Officer3.9yrsUS$2.82m0.070%
$ 1.4m
Warren Foust
Chief Operating Officer1.2yrsUS$3.42m0.0089%
$ 179.6k
Keith Holliday
Chief Technology Officer7.3yrsUS$2.41m0.036%
$ 732.7k
Scott Barnes
Chief Medical Officer6.7yrsUS$2.48m0.064%
$ 1.3m
Brian Moore
Vice President of Investor Relations & Corporate Developmentno dataデータなしデータなし
Nathaniel Sisitsky
General Counsel & Corporate Secretaryless than a yearデータなしデータなし
Nancy Sabin
Chief Marketing Officerless than a yearデータなしデータなし
James Francese
Senior Vice President of Commercial Operations - North America & APAC7.6yrsUS$2.54m0.060%
$ 1.2m
Magda Michna
Chief Clinical1.2yrsデータなし0.0061%
$ 124.1k
Robert Studholme
Senior Vice President of Operationsno dataデータなし0.066%
$ 1.3m

1.4yrs

平均在職期間

60.5yo

平均年齢

経験豊富な経営陣: STAAの経営陣は 経験豊富 とはみなされません ( 1.4年の平均在職年数)。これは新しいチームを示唆しています。


取締役

名称ポジション在職期間報酬所有権
Thomas Frinzi
President4yrsUS$10.22m0.046%
$ 938.3k
Stephen Farrell
Lead Independent Director8.4yrsUS$294.87k0.023%
$ 462.0k
Aimee Weisner
Independent Director2yrsUS$259.96k0.0076%
$ 154.5k
Kin-Hung Yu
Independent Director3.4yrsUS$249.98k0.0022%
$ 44.4k
Lilian Zhou
Independent Directorless than a yearUS$99.69k0.0017%
$ 35.0k
Brian Williams
Member of Optometric Advisory Council15.6yrsデータなしデータなし
Elizabeth Lin
Independent Director3.4yrsUS$249.99k0.0058%
$ 117.7k
Arthur Crosswell Butcher
Independent Directorless than a yearデータなし0%
$ 0
Wei Jiang
Independent Directorless than a yearデータなし0%
$ 0

3.4yrs

平均在職期間

57yo

平均年齢

経験豊富なボード: STAAの 取締役会経験豊富 であると考えられます ( 3.4年の平均在任期間)。